Eurofarma is named, for the 4th consecutive year, the best pharmaceutical company to work for in Latin America
New recognition reaffirms a culture of excellence and commitment to employee well-being and development.
São Paulo, August 22, 2025 – Eurofarma, a Brazilian multinational operating in 24 countries and across all of Latin America, has once again been recognized by Great Place to Work (GPTW) as the best pharmaceutical company to work for in the region. The company ranked 6th overall in the Best Workplaces™ – Latin America 2025 Ranking, its best result to date, highlighting its culture of care, safety, and excellence.
This achievement is a direct reflection of Eurofarma’s people-first strategy. In every country where it operates—including Brazil, its largest operation and the place where it began 53 years ago—the company believes that development, well-being, and value creation come from an integrated approach to its more than 13,000 employees and their families.
“This recognition reflects our commitment to strengthening the Eurofarma Way, a culture in which people are the central pillar of our strategy and growth. For us, being one of the best companies to work for is not just a seal of approval, but proof that we are on the right path by investing in attracting, developing, and retaining top talent. Having 92% of our employees proud to be part of this journey and filling 70% of leadership positions through internal promotions is something that makes us extremely proud,” says Daniela Panagassi, Vice President of People and Organization.
In 2025, the company has already been featured in several other GPTW rankings, including GPTW Brazil – Diversity, GPTW Brazil – Health, GPTW Paraguay – Innovative Culture, as well as national rankings in Bolivia, Peru, Ecuador, Paraguay, the Caribbean, and Central America, among others.
To learn more about Eurofarma’s initiatives focused on employee well-being and development, visit: eurofarma.com/sustainability-report.
About Eurofarma
Founded in 1972, Eurofarma operates in the healthcare sector through the production and marketing of products and services that improve quality of life. With a focus on creating shared value, the company covers the main pharmaceutical segments, including prescription medicines, OTC and personal care, generics, hospital, oncology, and animal health, as well as contract manufacturing. With broad coverage across therapeutic classes, its portfolio includes more than 4,000 SKUs, meeting the needs of key medical specialties.
A leader in prescription drugs in Brazil—where it also ranks second in generics—Eurofarma is present in 24 countries, with full coverage across Latin America and operations in the U.S. and Africa. The company employs 13,300 people and operates 11 factories, producing a total of 600 million units in 2024. That same year, Eurofarma invested more than R$ 800 million in innovation projects and achieved net revenue of R$ 11 billion.